PHAR-RWEB0010 - Pharmacy - Recorded Webinars

Presented by Dr. Tasha Ramsey

Is there a vaccine question you would like answered? Email your suggestion to: tramsey@dal.ca Subject line: October Vaccine Webinar

As we enter the respiratory season, there are new RSV, COVID, and influenza vaccines to consider. Join us for a review of RSV, COVID, and influenza vaccines and frequently asked questions.

Objectives:

By the end of this presentation, participants should be able to:

1. Name the vaccines currently offered for RSV, COVID, and influenza.

2. Describe who is eligible for RSV, COVID, and influenza vaccines.

3. Discuss RSV, COVID, and influenza vaccination controversies.

4. List resources available for RSV, COVID, and influenza vaccines.

For support, please email dalcpe@dal.ca

Presented by: Oluwatoyin Adeleke, BPharm, MPharm (Pharmaceutical Science), PhD, DST/NRF Innovation Postdoctoral Fellow, Postdoctoral Researcher
Presented on: Friday, January 12, 2024, Available  until July 11, 2024

Every now and then, healthcare personnel encounter patients struggling with taking their medicines because of swallowing difficulties associated with solid dosage forms, specifically tablets and capsules. Consequently, it is common practice to resort to breaking or crushing of tablets, opening of capsules as well as mixing of fragmented tablets or capsule content with soft food or edible fluids to make ingesting medications easier. This webinar aims to discuss typical drug delivery technologies embedded in tablets and capsules, the problems that can occur when these dosage forms are manipulated to meet patient needs and the potential impact of these alterations on therapeutic outcomes.

For support, please email dalcpe@dal.ca

Presented by Dr. Shanna Trenaman
BScH(Chemistry), BSc(Pharm), ACPR, MAHSR, PhD

The goal of this webinar will be to identify medications with anticholinergic effects, outline the risks associated with anticholinergic medications with a focus on the risk of cognitive impairment or dementia, and to provide alternative management considerations.

For support, please email dalcpe@dal.ca

Presented by Dalhousie University Academic Detailing

This presentation will summarize evidence evaluating clinical efficacy and potential harms of SGLT-2 Inhibitors and GLP-1 Agonists in the treatment of T2DM.

Participants will learn key evidence-based prescribing pearls and of potential adverse effects and drug interactions that may occur with the use of these medications and mitigation strategies to reduce harm.

For support, please email dalcpe@dal.ca

Available until June 27, 2024
Presented by Kristen Mackinnon

By the end of this session, participants should be able to:

• Discuss how the scopes of practice for contraception management differ between the Atlantic provinces
• Access information and resources available for contraception management
• Utilize the tips and tricks to prepare and participate in hormonal contraception management at their practice site
• Gain confidence in their knowledge of contraception management and to apply that knowledge to their patient population

For support, please email dalcpe@dal.ca

Presented by Sarah Larose

This presentation will review background on conjunctivitis as well as an approach to assessing and caring for a patient experiencing allergic, bacterial and viral conjunctivitis. Particular attention will be focused on the assessment of a patient presenting with red eye to determine etiology of conjunctivitis and presence of red flags for referral.

For support, please email dalcpe@dal.ca

Presented by Dr. Natalie Kennie-Kaulbach
BSc(Pharm), ACPR, DipAdultEd, PharmD

Pharmacist preceptors play a critical role in supporting pharmacy learner professional identity formation (PIF), in which learners come to think, feel, and act like a member of their professional community. This virtual session will introduce participants to critical events related to PIF that can occur during experiential learning placements, as well as the role and contribution of preceptors to PIF.

Evidence-informed PIF approaches will be discussed, and participants will leave the session with strategies to intentionally support learner PIF in their precepting and teaching practices.

Learning Objectives:
At the end of the session, participants will be able to:

    Define professional identity formation (PIF) and discuss how preceptors have a role in supporting pharmacy learner PIF.
    Describe critical events for PIF in pharmacy learners during experiential learning placements.
    Identify strategies preceptors can intentionally use to support pharmacy learner PIF.

For support, please email dalcpe@dal.ca

Presented by: Heather Penney, BSc(Neurocience-Honors); BSc(Pharm)
Presented on: Wednesday, February 21, 2024, @ 7 PM

This webinar will provide a general refresher on lice & scabies assessment and treatment, incorporating up-to-date evidence and considering ongoing product shortages.

For support, please email dalcpe@dal.ca